Companies covered: EyeGate Pharmaceuticals Inc. (NASDAQ:EYEG), CoLucid Pharmaceuticals Inc. (NASDAQ:CLCD), People's Utah Bancorp (NASDAQ:PUB), Second Sight Medical Products, Inc. (NASDAQ:EYES), Ocular Therapeutix, Inc. (NASDAQ:OCUL), Tobira Therapeutics Inc. (NASDAQ:TBRA), Pfenex Inc. (AMEX:PFNX), Connecture, Inc. (NASDAQ:CNXR), Immune Design Corp. (NASDAQ:IMDZ), Tuniu Corporation (NASDAQ:TOUR), Milacron Holdings Corp. (NYSE:MCRN)
